Veerhealth Care

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE882C01035
  • NSEID: NIYATILEAS
  • BSEID: 511523
INR
19.50
-0.11 (-0.56%)
BSENSE

Dec 05

BSE+NSE Vol: 1.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Veerhealth Care
Guj. Terce Labs.
JFL Life
Vineet Laborator
Sandu Pharma.
ANG Lifesciences
Roopa Industries
Medi Caps
Mangalam Drugs
Mono Pharmacare
Medicamen Organ.
Why is Veerhealth Care Ltd ?
1
Weak Long Term Fundamental Strength with a -24.21% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.47
  • The company has been able to generate a Return on Equity (avg) of 2.72% signifying low profitability per unit of shareholders funds
2
Risky - Negative Operating Profits
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 4.64%, its profits have risen by 40% ; the PEG ratio of the company is 0.1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Veerhealth Care for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Veerhealth Care
1.72%
0.10
48.21%
Sensex
4.67%
0.40
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.02%
EBIT Growth (5y)
-24.21%
EBIT to Interest (avg)
-0.47
Debt to EBITDA (avg)
1.55
Net Debt to Equity (avg)
0.17
Sales to Capital Employed (avg)
0.62
Tax Ratio
11.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-0.45%
ROE (avg)
2.72%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
85
Industry P/E
29
Price to Book Value
1.76
EV to EBIT
-42.97
EV to EBITDA
42.97
EV to Capital Employed
1.65
EV to Sales
2.40
PEG Ratio
0.13
Dividend Yield
NA
ROCE (Latest)
-1.73%
ROE (Latest)
2.07%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET SALES(9M)

At Rs 14.09 cr has Grown at 33.18%

PAT(9M)

Higher at Rs 0.39 Cr

PBDIT(Q)

Highest at Rs 0.53 cr.

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Veerhealth Care
Profit After Tax (PAT) - Latest six months
Higher at Rs 0.49 cr
than preceding 12 month period ended Sep 2025 of Rs 0.39 cr
MOJO Watch
In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)

Net Sales - Nine Monthly
At Rs 14.09 cr has Grown at 33.18%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 0.53 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)